78 related articles for article (PubMed ID: 7233874)
1. [Use of adriablastin in the combination chemotherapy of disseminated breast cancer].
Korman DB; Borisov AI; Maslova IA; Pines EV
Vopr Onkol; 1981; 27(4):44-7. PubMed ID: 7233874
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy including anablastine in disseminated breast cancer].
Dement'eva IP; Ass NIa; Lipovich MM
Vopr Onkol; 1981; 27(5):10-3. PubMed ID: 6787799
[TBL] [Abstract][Full Text] [Related]
3. [Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].
Voznyĭ EK; Besova NS; Kurkina TV; Al'tshtuller IuB
Antibiotiki; 1984 Jun; 29(6):463-8. PubMed ID: 6476811
[TBL] [Abstract][Full Text] [Related]
4. [Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases].
Korman DB; Borisov AI; Maslova IA; Dobroskok LB
Vopr Onkol; 1980; 26(8):20-4. PubMed ID: 7415044
[TBL] [Abstract][Full Text] [Related]
5. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
6. [Adriamycin in the combined chemotherapy of metastatic breast cancer].
Izmaĭlova GE; Letiagin VP
Vestn Akad Med Nauk SSSR; 1986; (5):47-51. PubMed ID: 3727784
[No Abstract] [Full Text] [Related]
7. [Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer].
Gershanovich ML; Moiceenko VM; Orlova RV
Vopr Onkol; 1993; 39(1-3):26-32. PubMed ID: 8073671
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy in metastatic breast cancer].
Kuten A; Lev L; Mohaliver J; Robinson E
Harefuah; 1981 Feb; 100(3):118-20. PubMed ID: 7262675
[TBL] [Abstract][Full Text] [Related]
9. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
[TBL] [Abstract][Full Text] [Related]
10. [Regional therapy breast cancer liver metastases].
Lorenz M; Wiesner J; Staib-Sebler E; Encke A
Zentralbl Chir; 1995; 120(10):786-90. PubMed ID: 7502593
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV
Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895
[TBL] [Abstract][Full Text] [Related]
12. [Use of "split" courses of combination chemotherapy in breast cancer].
Dymarskiĭ LIu; Aleksandrova GI; Sanchakova AV
Vopr Onkol; 1981; 27(7):82-5. PubMed ID: 7269435
[TBL] [Abstract][Full Text] [Related]
13. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
Giordano SH; Booser DJ; Murray JL; Ibrahim NK; Rahman ZU; Valero V; Theriault RL; Rosales MF; Rivera E; Frye D; Ewer M; Ordonez NG; Buzdar AU; Hortobagyi GN
Clin Cancer Res; 2002 Nov; 8(11):3360-8. PubMed ID: 12429622
[TBL] [Abstract][Full Text] [Related]
14. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
15. [Cisplatin (platidiame) in the treatment of patients with disseminated breast cancer].
Sopkova V; Mechl Z
Vopr Onkol; 1986; 32(4):36-8. PubMed ID: 3705525
[TBL] [Abstract][Full Text] [Related]
16. [Results of a clinical study of carminomycin in primary disseminated forms, recurrences and metastases of breast cancer].
Danova LA; Trishkina EA; Gershanovich ML
Vopr Onkol; 1983; 29(2):46-51. PubMed ID: 6340345
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a phase II study.
Rigatos SK; Tsavdaridis D; Athanasiadis A; Stathopoulos JG; Stathopoulos GP
Oncol Rep; 2003; 10(6):1817-9. PubMed ID: 14534702
[TBL] [Abstract][Full Text] [Related]
18. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Ardavanis A; Mavroudis D; Kalbakis K; Malamos N; Syrigos K; Vamvakas L; Kotsakis A; Kentepozidis N; Kouroussis C; Agelaki S; Georgoulias V;
Cancer Chemother Pharmacol; 2006 Dec; 58(6):742-8. PubMed ID: 16718470
[TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
[TBL] [Abstract][Full Text] [Related]
20. [Adriamycin/cyclophosphamide: current standard in adjuvant therapy for breast carcinoma?].
Sauter C
Schweiz Med Wochenschr; 1994 Oct; 124(43):1879-81. PubMed ID: 7973513
[No Abstract] [Full Text] [Related]
[Next] [New Search]
